Leptin and interleukin-6 (IL-6) have proatherogenic effects, contributing to the development of classic risk factors for atherosclerosis including, arterial hypertension, diabetes mellitus (DM), endothelial dysfunction, inflammation and platelet activation [5]. The gene discussed is LEP; the disease is atherosclerosis.